Effect of Green Tea Extract and Soy Isoflavones on the Pharmacokinetics of Rosuvastatin in Healthy Volunteers

被引:7
|
作者
Zeng, Weiwei [1 ]
Hu, Miao [2 ]
Lee, Hon Kit [3 ,4 ]
Wat, Elaine [5 ,6 ]
Lau, Clara Bik San [5 ,6 ]
Ho, Chung Shun [3 ]
Wong, Chun Kwok [3 ,5 ,6 ]
Tomlinson, Brian [2 ,7 ]
机构
[1] Jinan Univ, Shenzhen Baoan Womens & Childrens Hosp, Shenzhen, Peoples R China
[2] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med Therapeut, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Dept Chem Pathol, Hong Kong, Peoples R China
[4] Tuen Mun Hosp, Dept Clin Pathol, Hong Kong, Peoples R China
[5] Chinese Univ Hong Kong, Inst Chinese Med, Hong Kong, Peoples R China
[6] Chinese Univ Hong Kong, State Key Lab Res Bioactiv & Clin Applicat Med Pl, Hong Kong, Peoples R China
[7] Macau Univ Sci & Technol, Fac Med, Macau, Peoples R China
来源
FRONTIERS IN NUTRITION | 2022年 / 9卷
关键词
ABCG2; drug interaction; EGCG; green tea; rosuvastatin; soy isoflavones; DENSITY-LIPOPROTEIN CHOLESTEROL; HERB-DRUG INTERACTIONS; PLASMA-CONCENTRATIONS; SUPPLEMENTATION; TRANSPORTERS; EXPRESSION; STATINS; SLCO1B1; BCRP; (-)-EPIGALLOCATECHIN-3-GALLATE;
D O I
10.3389/fnut.2022.850318
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background and AimGreen tea and soy products are extensively consumed in daily life. Research has shown that green tea catechins and soy isoflavones may influence the activity of drug metabolizing enzymes and drug transporters. We examined whether regular consumption of green tea extract or soy isoflavones affected the pharmacokinetics of a single dose of rosuvastatin in healthy subjects and whether any interactions were influenced by the polymorphism in the drug transporter ABCG2. Study DesignThis was an open-label, three-phase randomized crossover study with single doses of rosuvastatin. MethodsHealthy Chinese male subjects were given a single dose of rosuvastatin 10 mg on 3 occasions: 1. without herbs; 2. with green tea extract; 3. with soy isoflavone extract. The green tea and soy isoflavone extract were given at a dose containing EGCG 800 mg once daily or soy isoflavones-80 mg once daily for 14 days before statin dosing and at the same time as the statin dosing with at least 4-weeks washout period between phases. ResultsTwenty healthy male subjects completed the study and the intake of green tea extract significantly reduced the systemic exposure to rosuvastatin by about 20% reducing AUC(0-24h) from [geometric mean (% coefficient of variation)] 108.7 (28.9) h center dot mu g/L to 74.1 (35.3) h center dot mu g/L and C-max from 13.1 (32.2) mu g/L to 7.9 (38.3) mu g/L (P < 0.001 for both), without affecting the elimination half-life. The ABCG2 421C>A polymorphism had a significant effect on rosuvastatin exposure but no impact on the interaction with green tea. Soy isoflavones had no significant effect on rosuvastatin pharmacokinetics. ConclusionThis study showed that repeated administration of green tea extract significantly reduced the systemic exposure of rosuvastatin in healthy volunteers. These effects might be predicted to either reduce or increase the lipid-lowering effect of rosuvastatin depending on the mechanism of the effect.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Exposure of Fexofenadine, but Not Pseudoephedrine, Is Markedly Decreased by Green Tea Extract in Healthy Volunteers
    Misaka, Shingen
    Ono, Yuko
    Taudte, R. Verena
    Hoier, Eva
    Ogata, Hiroshi
    Ono, Tomoyuki
    Konig, Jorg
    Watanabe, Hiroshi
    Fromm, Martin F.
    Shimomura, Kenju
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (03) : 627 - 634
  • [22] The effect of grape seed extract on the pharmacokinetics of dextromethorphan in healthy volunteers
    Goey, Andrew K. L.
    Meijerman, Irma
    Beijnen, Jos H.
    Schellens, Jan H. M.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (11) : 1883 - 1890
  • [23] The effect of grape seed extract on the pharmacokinetics of dextromethorphan in healthy volunteers
    Andrew K. L. Goey
    Irma Meijerman
    Jos H. Beijnen
    Jan H. M. Schellens
    European Journal of Clinical Pharmacology, 2013, 69 : 1883 - 1890
  • [24] EFFECTS OF TELMISARTAN ON THE PHARMACOKINETICS OF ROSUVASTATIN IN HEALTHY VOLUNTEERS AND IN PATIENTS WITH HYPERCHOLESTEROLAEMIA
    Lee, H.
    Hu, M.
    Ho, C.
    Wong, C.
    Tomlinson, B.
    Hu, M.
    Ho, C.
    Wong, C.
    Tomlinson, B.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 69 - 69
  • [25] Rosuvastatin pharmacokinetics in Pakistani healthy volunteers in comparison with other population
    Shah, Yasar
    Iqbal, Zafar
    Ahmad, Lateef
    Khuda, Fazli
    Khan, Abad
    Ismail
    Hassan, Muhammad
    Zakiullah
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 32 (06) : 2725 - 2732
  • [26] Metabolism, excretion, and pharmacokinetics of rosuvastatin in healthy adult male volunteers
    Martin, PD
    Warwick, MJ
    Dane, AL
    Hill, SJ
    Giles, PB
    Phillips, PJ
    Lenz, E
    CLINICAL THERAPEUTICS, 2003, 25 (11) : 2822 - 2835
  • [27] Effect of Schisandra chinensis extract and Ginkgo biloba extract on the pharmacokinetics of talinolol in healthy volunteers
    Fan, L.
    Mao, X. -Q.
    Tao, G. -Y.
    Wang, G.
    Jiang, F.
    Chen, Y.
    Li, Q.
    Zhang, W.
    Lei, H. -P.
    Hu, D. -L.
    Huang, Y. -F.
    Wang, D.
    Zhou, H. -H.
    XENOBIOTICA, 2009, 39 (03) : 249 - 254
  • [28] Effects of Soy Isoflavones and Green Tea Extract on Simvastatin Pharmacokinetics and Influence of the SLCO1B1 521T &gt; C Polymorphism
    Zeng, Weiwei
    Hu, Miao
    Lee, Hon Kit
    Wat, Elaine
    Lau, Clara Bik San
    Ho, Chung Shun
    Wong, Chun Kwok
    Tomlinson, Brian
    FRONTIERS IN NUTRITION, 2022, 9
  • [29] Differential Effects of Tipranavir plus Ritonavir on Atorvastatin or Rosuvastatin Pharmacokinetics in Healthy Volunteers
    Pham, P. A.
    la Porte, C. J. L.
    Lee, L. S.
    van Heeswijk, R.
    Sabo, J. P.
    Elgadi, M. M.
    Piliero, P. J.
    Barditch-Crovo, P.
    Fuchs, E.
    Flexner, C.
    Cameron, D. W.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (10) : 4385 - 4392
  • [30] Lack of effect of ketoconazole on the pharmacokinetics of rosuvastatin in healthy subjects
    Cooper, KJ
    Martin, PD
    Dane, AL
    Warwick, MJ
    Raza, A
    Schneck, DW
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 55 (01) : 94 - 99